ArticleCancer medicine2021

Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross-sectional and longitudinal analysis using two large national registries.

Avirup Guha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.